跳至主要内容
临床试验/NCT05483088
NCT05483088已完成不适用

Urine Sample Processing Study: Analysis of Fresh Versus Frozen Urine Samples From ICU Subjects

Astute Medical, Inc.1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2021年11月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
110
试验地点
1
主要终点
Stability of CCL14 in urine samples

研究概览

简要总结

The objective of the study is to collect and process urine samples from Intensive Care Unit (ICU) subjects with moderate to severe (Stage 2 or 3) acute kidney injury (AKI) for use in assessing the effects of urine sample freezing and various storage conditions on NEPHROCLEAR™ CCL14 Test results. This study is observational and will have no impact on the medical management of the subject.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females 21 years of age or older;
  • Receiving care in an intensive care unit;
  • Expected to remain in the ICU for at least 48 hours after enrollment;
  • Use of indwelling urinary catheter as standard care at the time of enrollment;
  • Subject must have acute kidney injury (KDIGO Stage 2 or Stage 3) at the time of sample collection;
  • Urine sample must be collected within 36 hours of meeting KDIGO Stage 2 criteria;
  • Written informed consent provided by patient or legally authorized representative (LAR).

排除标准

  • Prior kidney transplantation;
  • Comfort-measures-only status;
  • Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment;
  • Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic);
  • Special populations, pregnant women, prisoners or institutionalized individuals.

结局指标

主要结局

Stability of CCL14 in urine samples

时间窗: Up to 24 hours

Stability of CCL14 in urine samples as measured by the NEPHROCLEAR™ CCL14 Test

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验